CME Group Inc. (CME) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CME Revenue Growth
Revenue Breakdown (FY 2025)
CME's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
CME Revenue Analysis (2014–2025)
As of May 6, 2026, CME Group Inc. (CME) generated trailing twelve-month (TTM) revenue of $6.76 billion, reflecting strong growth of +14.5% year-over-year. The most recent quarter (Q1 2026) recorded $1.88 billion in revenue, up 14.0% sequentially.
Looking at the longer-term picture, CME's 5-year compound annual growth rate (CAGR) stands at +6.0%, indicating steady revenue expansion. The company achieved its highest annual revenue of $6.52 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows CME's business is primarily driven by clearing and transaction fees (81%), MarketData (12%), and OtherRevenue (7%). With over half of revenue concentrated in clearing and transaction fees, the company maintains significant focus in this area while developing other growth vectors.
When compared to Financial Services sector peers including ICE, CBOE, and NDAQ. Compare CME vs ICE →
CME Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CMECurrent | $6.8B | +14.5% | +6.0% | 64.9% | |
 ICE | $12.6B | - | - | 38.7% | |
 CBOE | $4.7B | - | - | 32.1% | |
 NDAQ | $8.2B | - | - | 28.4% | |
 MKTX | $817M | - | - | 41.7% | |
 MSCI | $3.1B | - | - | 54.7% |
CME Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.52B | - | $5.61B | 86.1% | $4.23B | 64.9% |
| 2024 | $6.13B | - | $5.28B | 86.1% | $3.93B | 64.1% |
| 2023 | $5.58B | - | $4.75B | 85.1% | $3.44B | 61.6% |
| 2022 | $5.02B | - | $4.27B | 85.0% | $3.02B | 60.1% |
| 2021 | $4.69B | - | $3.85B | 82.2% | $2.65B | 56.4% |
| 2020 | $4.88B | - | $4.03B | 82.5% | $2.64B | 54.0% |
| 2019 | $4.87B | - | $3.97B | 81.5% | $2.59B | 53.2% |
| 2018 | $4.31B | - | $3.64B | 84.4% | $2.61B | 60.5% |
| 2017 | $3.64B | - | $3.08B | 84.5% | $2.31B | 63.4% |
| 2016 | $3.60B | - | $3.05B | 84.9% | $2.20B | 61.2% |
Full CME Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See CME's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CME Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CME vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonCME — Frequently Asked Questions
Quick answers to the most common questions about buying CME stock.
Is CME's revenue growth accelerating or slowing?
CME maintains +14.5% revenue growth, in line with its 5-year CAGR of +6.0%. TTM revenue stands at $6.8B. Growth rate remains consistent with historical average.
What is CME's long-term revenue growth rate?
CME Group Inc.'s 5-year revenue CAGR of +6.0% reflects the sustained expansion pattern. Current YoY growth of +14.5% is near this long-term average.
How is CME's revenue distributed by segment?
CME reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.